Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...
Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial clinical data expected in Q4 2025 CLN-619 on-track for initial expansion...
CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted...
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.5875 | -4.39827812091 | 13.3575 | 13.52 | 12.04 | 615500 | 12.56567245 | CS |
| 4 | -3.24 | -20.2373516552 | 16.01 | 17.5034 | 12.04 | 558950 | 14.95897529 | CS |
| 12 | -6.66 | -34.276891405 | 19.43 | 19.89 | 12.04 | 540540 | 16.42910671 | CS |
| 26 | -11.66 | -47.7282030291 | 24.43 | 24.9869 | 12.04 | 664206 | 17.74807539 | CS |
| 52 | 4.07 | 46.7816091954 | 8.7 | 30.1886 | 7.64 | 610056 | 18.38475121 | CS |
| 156 | -5.94 | -31.7477284874 | 18.71 | 30.1886 | 7.3 | 375064 | 15.32762612 | CS |
| 260 | -29.23 | -69.5952380952 | 42 | 59.85 | 7.3 | 347826 | 18.08728508 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
